Impact Factor: 1.4

Artículos originales \ Clinical trial reviews

Cerebral embolic protection device in TAVI after the REFLECT II clinical trial: does it change our strategy?

Luis Nombela-Franco, and Gabriela Tirado-Conte

Instituto Cardiovascular, Hospital Clínico San Carlos, Instituto de Investigación del Hospital Clínico San Carlos (IdISSC), Madrid, Spain

REC Interv Cardiol. 2021;3:55-58

The POPular TAVI trial. Antithrombotic therapy following TAVI: towards a minimalist strategy

Josep Rodés-Cabau

Quebec Heart and Lung Institute, Laval University, Quebec City, Quebec, Canada

REC Interv Cardiol. 2020;2:298-301

ISCHEMIA trial: what is the role of revascularization in patients with chronic coronary syndromes?

Pablo Avanzasa,b,c, and Héctor Cubero-Gallegoa

aServicio de Cardiología, Hospital Universitario Central de Asturias, Oviedo, Asturias, Spain

bDepartamento de Medicina, Universidad de Oviedo, Oviedo, Asturias, Spain

cInstituto de Investigación Sanitaria del Principado de Asturias (ISPA), Oviedo, Asturias, Spain

REC Interv Cardiol. 2020;2:150-152

Onyx ONE trial: a new option in patients at high risk of bleeding

Íñigo Lozano and José Miguel Vegas

Servicio de Cardiología, Hospital de Cabueñes, Gijón, Spain

REC Interv Cardiol. 2020;1:55-58

COMPLETE revascularization after STEMI? Sure, go ahead

José López-Sendón and Raúl Moreno

Servicio de Cardiología, Hospital Universitario La Paz, IdiPaz, Universidad Autónoma de Madrid, CIBER-CV, Madrid, Spain

REC Interv Cardiol. 2019;3:203-206

DinoSAVR struck by the TAVR asteroids

Giuseppe Tarantini and Luca Nai Fovino

Department of Cardiac, Thoracic and Vascular Sciences, University of Padua Medical School, Padua, Italy

REC Interv Cardiol. 2019;2:131-135

Aspirin-free antithrombotic management following coronary stenting. Myth or reality?

Davide Capodannoa, Roxana Mehranb and Dominick J. Angiolilloc,

aDivision of Cardiology, CAST, P.O. “Rodolico”, Azienda Ospedaliero-Universitaria “Policlinico-Vittorio Emanuele”, University of Catania, Catania, Italy

bIcahn School of Medicine at Mount Sinai, New York, NY, United States

cDivision of Cardiology, University of Florida College of Medicine, Jacksonville, FL, United States

REC Interv Cardiol. 2019;1:62-66